Respiratory Disease News and Research

RSS

Chicken pox vaccine reduced related deaths by 88%

The team of researchers found that although in 2006 a second dose was added to the vaccination roster, the decrease in deaths occurred largely during the time when just one shot was recommended. While chickenpox-related deaths are now relatively rare, the new two-dose regimen may eliminate them altogether, they said. The double dose will further reduce sick days and medical care associated with chickenpox and its complications, the study authors said.

25 Jul 2011

Breathing problems trouble U.S. soldiers returning from Iraq and Afghanistan, speculation about inhaled toxins

According to a new study some U.S. soldiers returning from Iraq and Afghanistan are suffering unexplained breathing problems that may be related to exposure to unknown toxins.

21 Jul 2011

U.S. FDA approves 2011-2012 influenza vaccine formulation

The U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce and distribute influenza vaccine for the United States.

19 Jul 2011

Flu vaccine for 2011-12 season approved and ready

According to an announcement from the Food and Drug Administration (FDA) on Monday, it has approved the new flu vaccine for the season beginning this year. Each year the FDA works with other federal agencies and global health experts to design a vaccine to protect against the three viral strains most likely to cause the flu.

19 Jul 2011

CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII

CSL Behring has donated more than 1 million international units (IU) of von Willebrand factor (VWF)/Factor VIII (FVIII) replacement medication to patients through the World Federation of Hemophilia (WFH). The donation supports WFH's progress in improving the diagnosis and treatment of bleeding disorders in developing countries through its Global Alliance for Progress (GAP) program.

18 Jul 2011

New paper provides unique review on respiratory disorders in the Middle East

Lung diseases in the Middle East range from the centuries-old pulmonary tuberculosis (TB) to modern manifestations caused by chemical warfare. A new paper now available in Respirology, a journal of the Asian Pacific Society of Respirology, provides pulmonologists and patients with the first comprehensive review of respiratory illnesses specific to the Persian Gulf region, and the challenges in treating them.

14 Jul 2011

Dummy inhalers trick asthma patients to breathe easier: Study

A new study shows that dummy pills or placebo can act in asthma patients effectively making them think that real and fake drugs were doing the same level of good, even though the real medication actually had a much greater physical effect on their lungs. The effect was so strong that it convinced patients they were breathing much better even if they hadn't taken a real drug and hadn't actually improved much, as measured by a breathing test.

13 Jul 2011

FDA approves BOOSTRIX to prevent tetanus, diphtheria and pertussis in older people

The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX for use in adults 65 years of age and older for active booster immunization against tetanus, diphtheria and pertussis.

11 Jul 2011

Respira reports results of DPI drug engine clinical study against COPD, asthma

Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, today announced the results of a clinical feasibility study of the Company's drug engine technology.

21 Jun 2011

Respira introduces breakthrough Dry Powder Inhaler

Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, introduces the company's Dry Powder Inhaler (DPI) as a breakthrough solution for the pharmaceutical industry. Based on proprietary drug engine technology (DET), Respira Therapeutics' DPI significantly improves therapeutic performance and enables addressing the unmet medical needs of patients with severe respiratory diseases.

9 Jun 2011

European Commission grants Orphan Drug Designation for CSL Behring's rVIIa-FP to treat hemophilia

CSL Behring announced today that it has been granted Orphan Drug Designations by the European Commission for the development of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia B patients with inhibitors.

1 Jun 2011

Whooping cough on the rise mandates continuation of vaccine drive

A sharp rise in the number of whooping cough (Pertussis) cases has prompted the New South Wales Government to extend a free vaccine program until at least the end of the year. The health authorities say it is extremely important for infants and older children to be vaccinated on time.

24 May 2011

New study shows that closing schools, other measures limited H1N1 spread in Mexico

The H1N1 virus was new, and most of the cases occurred among young people. Health professionals and scientists weren’t sure at the onset what the world would encounter with the virus.

24 May 2011

Novel hepatitis C-like virus discovered in dogs

In a study to be published online this week in the Proceedings of the National Academy of Sciences, researchers report the discovery of a novel hepatitis C-like virus in dogs. The identification and characterization of this virus gives scientists new insights into how hepatitis C in humans may have evolved and provides scientists renewed hope to develop a model system to study how it causes disease.

24 May 2011

Expert review of respiratory medicine on pulmonary hypertension

Pulmonary hypertension (PH) is a rare, often incurable lung disorder that affects individuals of all ages, races and ethnic backgrounds. In the recent 4th World Conference on Pulmonary Hypertension held by the WHO, PH was classified into five groups based on its causes, highlighting both the magnitude of conditions associated with PH and how little we know of the etiology in many cases.

23 May 2011

Lung protein appears to play a key role in smoking-related emphysema

An international research team has identified a lung protein that appears to play a key role in smoking-related emphysema and have crafted an antibody to block its activity, Indiana University scientists reported.

17 May 2011

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

InterMune, Inc. today announced that an oral presentation and a poster presentation related to the company's development program for pirfenidone in idiopathic pulmonary fibrosis will be presented at the 2011 International Conference of the American Thoracic Society, being held in Denver May 13-18, 2011.

16 May 2011

Respiratory Disease News and Research

Chicken pox vaccine reduced related deaths by 88%

Breathing problems trouble U.S. soldiers returning from Iraq and Afghanistan, speculation about inhaled toxins

U.S. FDA approves 2011-2012 influenza vaccine formulation

Flu vaccine for 2011-12 season approved and ready

CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII

New paper provides unique review on respiratory disorders in the Middle East

Dummy inhalers trick asthma patients to breathe easier: Study

FDA approves BOOSTRIX to prevent tetanus, diphtheria and pertussis in older people

Respira reports results of DPI drug engine clinical study against COPD, asthma

Respira introduces breakthrough Dry Powder Inhaler

European Commission grants Orphan Drug Designation for CSL Behring's rVIIa-FP to treat hemophilia

Whooping cough on the rise mandates continuation of vaccine drive

New study shows that closing schools, other measures limited H1N1 spread in Mexico

Novel hepatitis C-like virus discovered in dogs

Expert review of respiratory medicine on pulmonary hypertension

Lung protein appears to play a key role in smoking-related emphysema

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

Vitamin D may improve exercise capacity, respiratory muscle strength in COPD patients

Zaire ebolavirus may replicate in pigs and transmit to other animals

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News